China Puts Priority on Biotech

"China biotech is hot" was the opinion of prominent pharma executives at the recent Bio-Europe Spring 2016 conference. Taking a lead from China's Premier Li Keqiang, biotech has become a national priority, and deals -- especially cross-border agreements -- have become very popular. At Bio-Europe, a panel discussion, "Opportunities for Cross-Border Partnering and Fundraising in China," led by Dr. Robert Narquizian, VP of International Business Development at ChinaBio®, detailed the panelists' experience with the upswing in deal-making activity. We present highlights of their thoughts, reprinted from partnership360 with their permission.
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.